[DOI] [PMC free article] [PubMed] [Google Scholar] 78.Bain MA, Faull R, Fornasini G, Milne RW, Evans AM
As interest in longevity medicine grows, BPC-157 peptide therapy is emerging as a compelling option for patients seeking to address pain, inflammation, and tissue recovery through science-backed regenerative means
( g-i ) Characterization of LiKO mice, including body weight ( g ), circulating glucose ( h ), and insulin ( i )
Individuals who are pregnant, under 18, or have medical conditions should consult a healthcare professional before use
12 hours | Primary site of action: extracellular matrix, gene expression | Key receptors: TGF-beta, MMP/TIMP | Research focus: skin regeneration, anti-aging, collagen | Endogenous: yes (plasma component) | Gene modulation: over 4,000 genes BPC-157 Half-life: approx